The George Washington (GW) University recently shared the publication of its new study in the Journal of Drugs in Dermatology.1
The study, titled, “The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa,” reported levels of treatment dissatisfaction among patients with hidradenitis suppurativa (HS) and assessed patient awareness of FDA-approved treatments and therapies.2
Hurley Stage I hidradenitis suppurativa of axilla | Image Credit: © DermNet
Background and Methods
To better understand treatment experiences and awareness among individuals with HS and uncover gaps in patient knowledge and access to recommended treatments, researchers conducted a voluntary online survey.
Hosted on SurveyMonkey and shared via the HSconnect.org listserv, the survey was open to adults…